Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash & Equivalents (2016 - 2026)

Exponent (EXPO) has disclosed Cash & Equivalents for 16 consecutive years, with $231.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 14.04% year-over-year to $231.8 million, compared with a TTM value of $231.8 million through Jul 2025, up 14.04%, and an annual FY2025 reading of $258.9 million, up 38.34% over the prior year.
  • Cash & Equivalents was $231.8 million for Q3 2025 at Exponent, down from $245.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $297.7 million in Q4 2021 and bottomed at $125.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $200.6 million, with a median of $197.5 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents skyrocketed 50.71% in 2021, then tumbled 45.76% in 2022.
  • Year by year, Cash & Equivalents stood at $297.7 million in 2021, then crashed by 45.76% to $161.5 million in 2022, then rose by 15.91% to $187.2 million in 2023, then increased by 8.61% to $203.3 million in 2024, then rose by 14.04% to $231.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for EXPO at $231.8 million in Q3 2025, $245.1 million in Q2 2025, and $258.9 million in Q1 2025.